Shopping Cart
- Remove All
- Your shopping cart is currently empty
123B9 is a tumor-homing agent characterized as a potent and selective agonist for EphA2 with a dissociation constant (Kd) of 4.0 μM. It specifically targets the ligand-binding domain of the EphA2 tyrosine kinase receptor. Notably, 123B9 does not significantly inhibit the ligand-binding domains of closely related receptors EphA3 and EphA4.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | 123B9 is a tumor-homing agent characterized as a potent and selective agonist for EphA2 with a dissociation constant (Kd) of 4.0 μM. It specifically targets the ligand-binding domain of the EphA2 tyrosine kinase receptor. Notably, 123B9 does not significantly inhibit the ligand-binding domains of closely related receptors EphA3 and EphA4. |
In vivo | Following intravenous administration of 123B9 at a dosage of 30 mg/kg in mice, the compound was detectable in the plasma over time at each tested interval (30 minutes, 1 hour, 2 hours, 4 hours). Plasma concentrations of the compound averaged 447 ng/mL and 569 ng/mL at the 2-hour and 4-hour marks, respectively. |
Molecular Weight | 1321.79 |
Formula | C58H82ClFN12O20 |
Cas No. | 2225868-19-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.